Implication for health policy/practice/research/medical education:
Studies suggested that serum lipoprotein (a) [Lp (a)] concentration may take part in aggravation of diabetic nephropathy. In contrast, some investigators believe that, the association of Lp (a) with diabetic nephropathy is likely to be weak or nonexistent. It seems that serum Lp (a) can be considered as a promising predictive factor for the diagnosis of earlier diabetic nephropathy, However, prospective studies are needed to determine its role.
Please cite this paper as: Baradaran A. Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathology. 2012; 1(3): 126-129. DOI: 10.5812/nephropathol.8107